Funding for this research was provided by:
VINNOVA (2016-02529 and 2016-03847)
Allmänna Sjukhusets i Malmö Stiftelse för Bekämpande av Cancer
Fru Berta Kamprads Stiftelse
Eurostars programme of the European Commision (E! 12326 ILLUMINUS)
Bekämpning av cancersjukdomar, Lund, SUS foundation, Region Skåne
Received: 3 September 2020
Accepted: 23 March 2021
First Online: 7 April 2021
: This study was reviewed and approved by the ethical review board in Lund (No. 2018/445). A written informed consent was obtained from all participants.
: Not applicable.
: C.S. is an employee of Spectronic Medical AB. The other authors declare that they have no competing interest.